Not when but how. EMA aims to start proactively publishing EU clinical trial data in Jan 2014; now it just has to decide on the detail
This article was originally published in SRA
Executive Summary
Starting January 2014, the European Medicines Agency intends to start proactively releasing clinical trial data for EU drugs on which a marketing authorisation decision has been taken1,2.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.
EMA To Get The Ball Rolling On Making CTIS Global
The European Medicines Agency wants to further improve the visibility of data in the Clinical Trials Information System by establishing it as a World Health Organization primary registry.